Nucleotide substitution: G1513A. Amino acid replacement: D382N.
G21555955A
G1513A
D382N | Egfr-PA; D431N | Egfr-PB
D382N
Egfrt1/Egfrtop-EC20 animals display rotation defects in adult ommatidia.
Enhances the female sterility and adult morphological defects of Egfrt1. Rarely survives as transheterozygote with the semi-viable Egfrtop-CA allele.
Does not suppress the "Ellipse" phenotype. Hemizygotes die during pupariation, and have abnormally small dorsal imaginal discs.
Homozygous embryos show no defects, hemizygotes are pupal lethal. When in combination with Df(2R)Egfr3 the eye-antennal, wing and haltere imaginal discs give rise to eyes, wings and halteres that are reduced size due to altered development of the imaginal disc. Embryos produced from heteroallelic combination with Egfrt1 have a severe ventralised phenotype, reduction in size of their dorsal appendage.
Egfr[+]/Egfrtop-EC20 is a non-enhancer of anterior crossvein phenotype of Scer\GAL4en-e16E, Socs36EUASp.cCa
Egfrtop-EC20, Scer\GAL4en-e16E, Socs36EUASp.cCa has wing vein | ectopic phenotype
Egfrtop-EC20, Scer\GAL4en-e16E, Socs36EUASp.cCa has wing vein L4 phenotype
Egfr[+]/Egfrtop-EC20, Scer\GAL4en-e16E, Socs36EUASp.cCa has wing vein | ectopic phenotype
Egfr[+]/Egfrtop-EC20, Scer\GAL4en-e16E, Socs36EUASp.cCa has wing vein L4 phenotype
Expression of Socs36EScer\UAS.P\T.cCa under the control of Scer\GAL4en-e16E in a Egfrtop-EC20/+ background results in ectopic wing vein material in 86% of flies and occasional thinning of a section of the L4 longitudinal wing vein. The anterior crossvein loss phenotype of Socs36EScer\UAS.P\T.cCa-expressing flies is not affected.
Mutation of Egfr that coordinately affects all gene activities, a class I lesion. The allelic series for class I lesions: Egfrt2 = Egfrt1 < Egfrtop-EC20 < Egfrf7 = Egfrf1 = Egfrflb-2E07 < Egfrtop-EE39 = Egfrtop-ED26 = Egfrf5 < Egfrf9 = Egfrf10 = Egfrf2 = Egfrtop-EE42 = Egfrf11 = Egfrf24 = Egfrf3 = Df(2R)Egfr3.
Class I allele.